Title : High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.

Pub. Date : 2016 Oct

PMID : 27456384






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We describe 2 open-label phase 2 studies investigating the efficacy and safety of ABT-493 plus ABT-530 with or without ribavirin (RBV) in GT1- or GT3-infected patients with compensated cirrhosis. Ribavirin beta-1,4-galactosyltransferase 1 Homo sapiens